Immunogenicity of the seven valent pneumococcal conjugate vaccine in patients with ataxia-telangiectasia

Pediatr Infect Dis J. 2004 Mar;23(3):269-70. doi: 10.1097/01.inf.0000115737.35353.55.

Abstract

Immune responses to a 7-valent pneumococcal conjugate vaccine were determined in 10 patients with ataxia-telangiectasia who are at high risk for pneumococcal disease because of immunodeficiency. Pneumococcal antibody titers for 7 serotypes measured increased 2.0- to 7.5-fold after immunization.

MeSH terms

  • Adolescent
  • Adult
  • Ataxia Telangiectasia / immunology*
  • Bacterial Vaccines / immunology*
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Male
  • Pneumococcal Infections / prevention & control*
  • Pneumococcal Vaccines / immunology*
  • Polysaccharides, Bacterial
  • Vaccines, Conjugate

Substances

  • Bacterial Vaccines
  • Pneumococcal Vaccines
  • Polysaccharides, Bacterial
  • Vaccines, Conjugate